By analyzing E. coli protein levels, scientists found a surplus of membrane shuttle proteins that may play a role in ...
Cornell researchers have identified a key protein mechanism that helps bacteria expel antibiotics, making them more resistant ...
A Cornell University-led collaboration has uncovered the equipment that enables bacteria to survive exposure to antibiotics: ...
AbbVie has claimed FDA approval for Emblaveo, a new antibiotic product to treat complicated intra-abdominal infections (cIAI) ...
AbbVie has announced that the US Food and Drug Administration (FDA) has approved its Pfizer-partnered Emblaveo ...
Research into developing new antimicrobial resistance treatment in Nigeria and other low/middle-income countries has fuelled ...
Research into developing new antimicrobial resistance treatments in Nigeria and other low/middle-income countries has secured ...
ARE you having a lovely long weekend with your significant other this Valentine’s Day and the two of you have booked a romantic getaway? Unless you own a cosy cottage somewhere, you most ...
The FDA has approved Emblaveo with metronidazole for patients with complicated intra-abdominal infections and limited options.
Emblaveo marks the first and only fixed-dose intravenous monobactam/β-lactamase inhibitor combination antibiotic to be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback